{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:35:47Z","timestamp":1775165747770,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872793"],"award-info":[{"award-number":["31872793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies demonstrated that mast cells with their degranulated component heparin are the major endogenous factors that stimulate preadipocyte differentiation and promote fascial adipogenesis, and this effect is related to the structure of heparin. Regarding the structural and physiological properties of the negatively charged polymers, hexasulfonated suramin, a centuries-old medicine that is still used for treating African trypanosomiasis and onchocerciasis, is assumed to be a heparin-related analog or heparinoid. This investigation aims to elucidate the influence of suramin on the adipogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To assess the influence exerted by suramin on adipogenic differentiation of primary white adipocytes in rats, this exploration was conducted both in vitro and in vivo. Moreover, it was attempted to explore the role played by the sulfonic acid groups present in suramin in mediating this adipogenic process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Suramin demonstrated a dose- and time-dependent propensity to stimulate the adipogenic differentiation of rat preadipocytes isolated from the superficial fascia tissue and from adult adipose tissue. This stimulation was concomitant with a notable upregulation in expression levels of pivotal adipogenic factors as the adipocyte differentiation process unfolded. Intraperitoneal injection of suramin into rats slightly increased adipogenesis in the superficial fascia and in the epididymal and inguinal fat depots. PPADS, NF023, and NF449 are suramin analogs respectively containing 2, 6, and 8 sulfonic acid groups, among which the last two moderately promoted lipid droplet formation and adipocyte differentiation. The number and position of sulfonate groups may be related to the adipogenic effect of suramin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Suramin emerges as a noteworthy pharmaceutical agent with the unique capability to significantly induce adipocyte differentiation, thereby fostering adipogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01980-3","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:02:36Z","timestamp":1702458156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suramin, an antiparasitic drug, stimulates adipocyte differentiation and promotes adipogenesis"],"prefix":"10.1186","volume":"22","author":[{"given":"Hanxiao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"issue":"10","key":"1980_CR1","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1016\/S0021-9258(19)85559-X","volume":"255","author":"AK Student","year":"1980","unstructured":"Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem. 1980;255(10):4745\u201350.","journal-title":"J Biol Chem"},{"issue":"2","key":"1980_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbalip.2006.02.001","volume":"1761","author":"J He","year":"2006","unstructured":"He J, Jiang H, Tansey JT, Tang C, Pu S, Xu G. Calyculin and okadaic acid promote perilipin phosphorylation and increase lipolysis in primary rat adipocytes. Biochim Biophys Acta. 2006;1761(2):247\u201355.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1980_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbalip.2006.10.004","volume":"1771","author":"H Jiang","year":"2007","unstructured":"Jiang H, He J, Pu S, Tang C, Xu G. Heat shock protein 70 is translocated to lipid droplets in rat adipocytes upon heat stimulation. Biochim Biophys Acta. 2007;1771(1):66\u201374.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"1980_CR4","doi-asserted-by":"publisher","first-page":"3116S","DOI":"10.1093\/jn\/130.12.3116S","volume":"130","author":"RF Morrison","year":"2000","unstructured":"Morrison RF, Farmer SR. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr. 2000;130(12):3116S\u201321.","journal-title":"J Nutr"},{"issue":"1","key":"1980_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","volume":"92","author":"L Wang","year":"2014","unstructured":"Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, Schuster D, Kopp B, Bauer R, Stuppner H, Dirsch VM, Atanasov AG. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review. Biochem Pharmacol. 2014;92(1):73\u201389.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"1980_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00418-019-01812-5","volume":"152","author":"D Zhang","year":"2019","unstructured":"Zhang D, Dong Y, Zhang Y, Su X, Chen T, Zhang Y, Wu B, Xu G. Spatial distribution and correlation of adipocytes and mast cells in superficial fascia in rats. Histochem Cell Biol. 2019;152(6):439\u201351.","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"1980_CR7","doi-asserted-by":"publisher","first-page":"158585","DOI":"10.1016\/j.bbalip.2019.158585","volume":"1865","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Su X, Dong Y, Chen T, Zhang Y, Wu B, Li H, Sun X, Xia L, Zhang D, Wang H, Xu G. Cytological and functional characteristics of fascia adipocytes in rats: a unique population of adipocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(2):158585.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5","key":"1980_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/stem.2338","volume":"34","author":"X Su","year":"2016","unstructured":"Su X, Lyu Y, Wang W, Zhang Y, Li D, Wei S, Du C, Geng B, Sztalryd C, Xu G. Fascia Origin of Adipose cells. Stem Cells. 2016;34(5):1407\u201319.","journal-title":"Stem Cells"},{"issue":"6","key":"1980_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00418-019-01831-2","volume":"152","author":"DJ Taatjes","year":"2019","unstructured":"Taatjes DJ, Roth J. In focus in HCB. Histochem Cell Biol. 2019;152(6):391\u20135.","journal-title":"Histochem Cell Biol"},{"key":"1980_CR10","doi-asserted-by":"crossref","unstructured":"Dong YY, Zhang DD, Cao YR, Zhang YF, Sun XZ, Chen TS, Zhang YY, Xu GH. Mathematical analysis for spatial distribution of vessels, mast cells and adipocytes in superficial fascia. Front Physiol 2022, 13.","DOI":"10.3389\/fphys.2022.1026019"},{"issue":"11","key":"1980_CR11","doi-asserted-by":"publisher","first-page":"159024","DOI":"10.1016\/j.bbalip.2021.159024","volume":"1866","author":"T Chen","year":"2021","unstructured":"Chen T, Zhang Y, Dong Y, Zhang D, Xia L, Sun X, Li H, Han C, Wang H, Xu G. Mast cell and heparin promote adipogenesis in superficial fascia of rats. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(11):159024.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"10110","key":"1980_CR12","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"P Buscher","year":"2017","unstructured":"Buscher P, Cecchi G, Jamonneau V, Priotto G. Human African Trypanosomiasis. Lancet. 2017;390(10110):2397\u2013409.","journal-title":"Lancet"},{"issue":"6","key":"1980_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/10520290903297528","volume":"85","author":"M Wainwright","year":"2010","unstructured":"Wainwright M. Dyes, Trypanosomiasis and DNA: a historical and critical review. Biotech Histochem. 2010;85(6):341\u201354.","journal-title":"Biotech Histochem"},{"issue":"4","key":"1980_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0277-5379(90)90005-E","volume":"26","author":"JP Armand","year":"1990","unstructured":"Armand JP, Cvitkovic E. Suramin: a new therapeutic concept. Eur J Cancer. 1990;26(4):417\u20139.","journal-title":"Eur J Cancer"},{"issue":"8456","key":"1980_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(85)90002-9","volume":"2","author":"S Broder","year":"1985","unstructured":"Broder S, Yarchoan R, Collins JM, Lane HC, Markham PD, Klecker RW, Redfield RR, Mitsuya H, Hoth DF, Gelmann E, et al. Effects of suramin on HTLV-III\/LAV Infection presenting as Kaposi\u2019s sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet. 1985;2(8456):627\u201330.","journal-title":"Lancet"},{"key":"1980_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","volume":"121","author":"IC Albulescu","year":"2015","unstructured":"Albulescu IC, van Hoolwerff M, Wolters LA, Bottaro E, Nastruzzi C, Yang SC, Tsay SC, Hwu JR, Snijder EJ, van Hemert MJ. Suramin inhibits Chikungunya virus replication through multiple mechanisms. Antiviral Res. 2015;121:39\u201346.","journal-title":"Antiviral Res"},{"key":"1980_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","volume":"13","author":"L Henss","year":"2016","unstructured":"Henss L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virol J. 2016;13:149.","journal-title":"Virol J"},{"issue":"3","key":"1980_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","volume":"28","author":"W Yin","year":"2021","unstructured":"Yin W, Luan X, Li Z, Zhou Z, Wang Q, Gao M, Wang X, Zhou F, Shi J, You E, Liu M, Wang Q, Jiang Y, Jiang H, Xiao G, Zhang L, Yu X, Zhang S, Eric Xu H. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat Struct Mol Biol. 2021;28(3):319\u201325.","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"1980_CR19","first-page":"3303","volume":"9","author":"MA Villalona-Calero","year":"2003","unstructured":"Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL. Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell Lung cancer. Clin Cancer Res. 2003;9(9):3303\u201311.","journal-title":"Clin Cancer Res"},{"key":"1980_CR20","doi-asserted-by":"crossref","unstructured":"Tian J, Lu Z, Niu S, Zhang S, Ying P, Wang L, Zhang M, Cai Y, Dong T, Zhu Y, Zhong R, Wang Z, Chang J, Miao X. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma. Clin Transl Med 2021, 11 (6), e485.","DOI":"10.1002\/ctm2.485"},{"key":"1980_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12935-015-0196-y","volume":"15","author":"H Li","year":"2015","unstructured":"Li H, Li H, Qu H, Zhao M, Yuan B, Cao M, Cui J. Suramin inhibits cell proliferation in ovarian and Cervical cancer by downregulating heparanase expression. Cancer Cell Int. 2015;15:52.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1980_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcp.1041320120","volume":"132","author":"RJ Coffey Jr","year":"1987","unstructured":"Coffey RJ Jr., Leof EB, Shipley GD, Moses HL. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol. 1987;132(1):143\u20138.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1980_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jcb.240290310","volume":"29","author":"M Hosang","year":"1985","unstructured":"Hosang M. Suramin binds to platelet-derived growth factor and inhibits its biological activity. J Cell Biochem. 1985;29(3):265\u201373.","journal-title":"J Cell Biochem"},{"key":"1980_CR24","doi-asserted-by":"crossref","unstructured":"Wiedemar N, Hauser DA, Maser P. 100 years of Suramin. Antimicrob Agents Chemother 2020, 64 (3).","DOI":"10.1128\/AAC.01168-19"},{"issue":"2","key":"1980_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1023\/A:1015666024386","volume":"20","author":"M Kaur","year":"2002","unstructured":"Kaur M, Reed E, Sartor O, Dahut W, Figg WD. Suramin\u2019s development: what did we learn? Invest New Drugs. 2002;20(2):209\u201319.","journal-title":"Invest New Drugs"},{"issue":"18","key":"1980_CR26","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/jnci\/81.18.1346","volume":"81","author":"J Corliss","year":"1989","unstructured":"Corliss J. Heparin analogues: a new family of anticancer Drugs. J Natl Cancer Inst. 1989;81(18):1346\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"1980_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jviromet.2011.03.021","volume":"174","author":"N Ohtaki","year":"2011","unstructured":"Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Todokoro M, Kurata T, Sata T, Kojima A. Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity cellufine sulfate column. J Virol Methods. 2011;174(1\u20132):131\u20135.","journal-title":"J Virol Methods"},{"issue":"Pt 1","key":"1980_CR28","first-page":"87","volume":"186","author":"J Chamberlain","year":"1995","unstructured":"Chamberlain J, Shah M, Ferguson MW. The effect of suramin on healing adult rodent dermal wounds. J Anat. 1995;186(Pt 1):87\u201396.","journal-title":"J Anat"},{"issue":"11","key":"1980_CR29","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/molecules13112758","volume":"13","author":"C Urbinati","year":"2008","unstructured":"Urbinati C, Chiodelli P, Rusnati M. Polyanionic Drugs and viral oncogenesis: a Novel Approach to Control Infection, tumor-associated inflammation and angiogenesis. Molecules. 2008;13(11):2758\u201385.","journal-title":"Molecules"},{"issue":"25","key":"1980_CR30","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.2174\/138161209789058156","volume":"15","author":"M Rusnati","year":"2009","unstructured":"Rusnati M, Urbinati C. Polysulfated\/Sulfonated compounds for the development of Drugs at the crossroad of viral Infection and Oncogenesis. Curr Pharm Design. 2009;15(25):2946\u201357.","journal-title":"Curr Pharm Design"},{"issue":"8","key":"1980_CR31","doi-asserted-by":"publisher","first-page":"190117","DOI":"10.1098\/rsob.190117","volume":"9","author":"CN Paulson","year":"2019","unstructured":"Paulson CN, John K, Baxley RM, Kurniawan F, Orellana K, Francis R, Sobeck A, Eichman BF, Chazin WJ, Aihara H, Georg GI, Hawkinson JE, Bielinsky AK. The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10. Open Biol. 2019;9(8):190117.","journal-title":"Open Biol"},{"issue":"1","key":"1980_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-002-0458-y","volume":"50","author":"CW Ryan","year":"2002","unstructured":"Ryan CW, Vokes EE, Vogelzang NJ, Janisch L, Kobayashi K, Ratain MJ. A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer. Cancer Chemother Pharmacol. 2002;50(1):1\u20135.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"1980_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.chom.2016.05.002","volume":"19","author":"S Trindade","year":"2016","unstructured":"Trindade S, Rijo-Ferreira F, Carvalho T, Pinto-Neves D, Guegan F, Aresta-Branco F, Bento F, Young SA, Pinto A, Van Den Abbeele J, Ribeiro RM, Dias S, Smith TK, Figueiredo LM. Trypanosoma Brucei parasites Occupy and functionally adapt to the adipose tissue in mice. Cell Host Microbe. 2016;19(6):837\u201348.","journal-title":"Cell Host Microbe"},{"key":"1980_CR34","doi-asserted-by":"crossref","unstructured":"Nagajyothi F, Weiss LM, Zhao D, Koba W, Jelicks LA, Cui MH, Factor SM, Scherer PE, Tanowitz HB. High fat diet modulates Trypanosoma Cruzi Infection associated Myocarditis. PLoS Negl Trop Dis 2014, 8 (10), e3118.","DOI":"10.1371\/journal.pntd.0003118"},{"key":"1980_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.fct.2018.07.031","volume":"120","author":"W Qi","year":"2018","unstructured":"Qi W, Clark JM, Timme-Laragy AR, Park Y. Perfluorobutanesulfonic acid (PFBS) potentiates adipogenesis of 3T3-L1 adipocytes. Food Chem Toxicol. 2018;120:340\u20135.","journal-title":"Food Chem Toxicol"},{"key":"1980_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.taap.2015.11.002","volume":"290","author":"J Xu","year":"2016","unstructured":"Xu J, Shimpi P, Armstrong L, Salter D, Slitt AL. PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway. Toxicol Appl Pharmacol. 2016;290:21\u201330.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"1980_CR37","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1021\/acs.est.7b06327","volume":"52","author":"CH Li","year":"2018","unstructured":"Li CH, Ren XM, Ruan T, Cao LY, Xin Y, Guo LH, Jiang G. Chlorinated Polyfluorinated Ether sulfonates exhibit higher activity toward peroxisome proliferator-activated Receptors Signaling pathways than Perfluorooctanesulfonate. Environ Sci Technol. 2018;52(5):3232\u20139.","journal-title":"Environ Sci Technol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01980-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01980-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01980-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:06:50Z","timestamp":1702458410000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01980-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1980"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01980-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the research protocol was secured from the Animal Care and Use Committee of Peking University Health Science Center, in adherence to ethical standards, with the assigned reference number of LA2019289.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"222"}}